Cardiopulmonary diseases are disorders that affect the normal functions of the heart and lungs. Disorders in any one organ can affect the other as well. For instance, a person with chronic heart disease has difficulty pumping oxygenated blood to the lungs. Cardiovascular diseases (CVDs) account for a major portion of cardiopulmonary diseases. Various organizations such as WHO state CVDs to be the main cause of mortality worldwide. A 2015 research study by WHO estimated that about 17.5 million people (31% of the total global population) worldwide died due to CVDs in 2012.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Cardiopulmonary diseases: An overview

Cardiopulmonary autotransfusion systems: An

overview

Role of autotransfusion in cardiac surgeries

Cardiopulmonary autotransfusion process

PART 05: Classification of medical devices

Classification of medical devices

PART 06: Cost analysis

Cost analysis of cardiopulmonary autotransfusion

systems

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation by end-user

Hospitals

ASCs

PART 09: Geographical segmentation

Cardiopulmonary autotransfusion systems market in

Americas

Cardiopulmonary autotransfusion systems market in

EMEA

Cardiopulmonary autotransfusion systems market in

APAC

PART 10: Market drivers

Rise in cardiac surgeries

Complications of allogenic blood transfusion

Advances in autotransfusion technology

PART 11: Impact of drivers

PART 12: Market challenges

Limitations of autotransfusion technology

Use of allogenic blood transfusion

Stringent regulatory framework and medical policies

PART 13: Impact of drivers and challenges

PART 14: Market trends

Development of ultrafiltration systems

Significant opportunities in emerging countries

Public awareness

PART 15: Vendor landscape

Competitive scenario

PART 16: Major vendors

Advancis Surgical

Fresenius Kabi

Haemonetics

LivaNova

Medtronic

Terumo

Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio